Sustainability & Climate

Michelin and Sonatus are set to reveal a digital tire twin at CES 2026, using AI to predict wear and tear and promising a future of safer, more efficient driving.

Dr. Ambroes Pass-Turner, a seasoned psychologist, launches a new podcast to help parents navigate complex issues, starting with ADHD.

A new line of vibration and bone-conduction sensors from Upbeat Technology aims to revolutionize voice AI, wearables, and drones with crystal-clear audio.

NDT Pharmaceuticals' subsidiary launches PurrGuard and Dog Gone Odor, leveraging antimicrobial tech to disrupt the multi-billion-dollar pet hygiene industry.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

Researchers at Kanazawa University have developed engineered nanoparticles that can reprogram rogue immune cells, offering a targeted therapy for autoimmune diseases.

T'way Air launches aggressive year-end deals for Seoul and Jeju, sparking a price war among low-cost carriers on the popular Singapore-Korea travel route.

With backing from AstraZeneca and Pfizer, Beijing’s Syneron Bio is using its AI-driven platform to develop novel drugs for cancer and chronic illness.

President Trump's order eases marijuana rules, but a new law threatens to dismantle the $28B hemp industry, creating unprecedented regulatory chaos.

The U.S. government is partnering with 24 tech leaders, including Accenture, on a mission to double R&D and secure global leadership in AI.

Industrial giant Fastenal partners with the Belfast Giants, a strategic move blending global business ambition with deep-rooted community engagement in NI.

Ottawa's National Gallery unveils new exhibits and family fun with free admission for youth, blending high art with interactive holiday experiences.

Facing a critical cash shortfall, Cue Biopharma turns to the market, betting its promising cancer and autoimmune pipeline can win over investors.

An executive order accelerates moving cannabis to Schedule III, promising massive tax breaks for businesses but leaving advocates wanting more federal reform.

For the first time, Medicare and Medicaid will cover CBD products for senior cancer patients, a landmark decision with massive implications for patients and markets.

Facing financial headwinds, Celularity lands a critical $12M from a top investor to push its ambitious anti-aging and regenerative therapies forward.

A new standing wheelchair module offers unprecedented height, blending advanced engineering with profound health and social benefits for users.

As pharma sells GLP-1s directly to patients, doctors are split on the new model. Is it a lifeline for access or a risk to integrated patient care?

Trinity Investments expands its European empire, acquiring The Hoxton, Poblenou in a move that highlights its multi-segment strategy in top-tier markets.

With the hire of a digital leader from brands like Google and Sonos, Unlock Health aims to bring modern, user-friendly tech to the healthcare industry.